NCT00295880 · OUTCOME

Number of Patients With Grade III-IV Acute Graft-versus-host Disease (GVHD)

Donor Umbilical Cord Blood Transplant By Injection Into the Bone Marrow in Treating Patients With Hematologic Cancer · Source last updated 2017-12-28

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

Number of umbilical cord blood transplant patients developing severe GVHD at 100 days post transplant.

Analysis population: 2 patients were not yet graded for acute gvhd

Patients with high-risk hematologic malignancy transplanted with umbilical cord blood via direct marrow injection.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Umbilical Cord Blood Transplant Patients	8

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Umbilical Cord Blood Transplant Patients	2	Not reported	Not reported	Not reported	Not reported

Complete source fields

anticipated Posting Date

2009-07

classes

denoms

description

Number of umbilical cord blood transplant patients developing severe GVHD at 100 days post transplant.

groups

param Type

NUMBER

population Description

2 patients were not yet graded for acute gvhd

reporting Status

POSTED

time Frame

100 days post transplant

title

Number of Patients With Grade III-IV Acute Graft-versus-host Disease (GVHD)

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice